High-Dose Chemotherapy in Ovarian Cancer: Still Waiting for the Right Study
- 1 January 2003
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 88 (1) , 1-2
- https://doi.org/10.1006/gyno.2002.6934
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Pilot Evaluation of High-Dose Carboplatin and Paclitaxel Followed by High-Dose Melphalan Supported by Peripheral Blood Stem Cells in Previously Untreated Advanced Ovarian Cancer: A Gynecologic Oncology Group StudyGynecologic Oncology, 2003
- High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term resultsBone Marrow Transplantation, 2000
- High dose chemotherapy with peripheral blood stem cell transplantation (PBSCT) in ovarian cancerInternational Journal of Gynecologic Cancer, 2000
- High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: long-term results.Journal of Clinical Oncology, 1997